Terminal modifications of tumor necrosis factor
    3.
    发明授权
    Terminal modifications of tumor necrosis factor 失效
    末端修饰肿瘤坏死因子

    公开(公告)号:US5262309A

    公开(公告)日:1993-11-16

    申请号:US668517

    申请日:1991-03-22

    CPC分类号: C07K14/525 A61K38/00

    摘要: This invention relates to a novel physiologically active polypeptide containing modified amino acids on both terminals at the amino-terminus and the carboxy-terminus in the amino acid sequence of the human tumor neclosis factor (human TNF), a recombinant plasmid containing a DNA region encoding the polypeptide, a recombinant microorganism cell transformed with the recombinant plasmid, a method of producing the polypeptide by cultivating the microorganism cell, a pharmaceutical composition containing the polypeptide and a method of purifying and recovering the polypeptide. The polypeptide in this invention has excellent antitumor activity compared to the human TNF and can be utilized as an active ingredient of a pharmaceutical composition having antitumor activity.

    摘要翻译: PCT No.PCT / JP89 / 00966 Sec。 371日期1991年3月22日 102(e)1991年3月22日PCT申请1989年9月22日PCT公开号 出版物WO90 / 03395 日本1994年4月5日。本发明涉及在人肿瘤坏死因子(人TNF)的氨基酸序列的氨基末端和羧基末端两端含有修饰氨基酸的新的生理活性多肽, 含有编码该多肽的DNA区域的重组质粒,用重组质粒转化的重组微生物细胞,通过培养微生物细胞产生该多肽的方法,含该多肽的药物组合物以及纯化和回收该多肽的方法。 本发明的多肽与人TNF相比具有优异的抗肿瘤活性,可用作具有抗肿瘤活性的药物组合物的活性成分。

    Human immunoglobulin and enhancer gene fragments
    4.
    发明授权
    Human immunoglobulin and enhancer gene fragments 失效
    人类免疫球蛋白和增强子基因片段

    公开(公告)号:US5101024A

    公开(公告)日:1992-03-31

    申请号:US326417

    申请日:1989-03-21

    摘要: The present invention provides an enhancer DNA segment, a gene fragment having (a) the enhancer DNA segment and (b) a structural gene such as human D, V and J gene, and a promoter. A hybrid DNA (1) having a phage DNA fragment from Charon 4A phage vector and human DNA fragments, a Charon 4A phage containing the hybrid DNA (1), a hybrid DNA (2) having a PBR322 fragment and human DNA fragment, a transformant of E. coli C600 strain transformed with the hybrid DNA (2), plasmid pSV2-H1G1 obtained by inserting a human DNA fragment into a vector pSV-2gpt, a transformant of E. coli MC 1000 strain transformed with the plasmid pSV2-H1G1 and a transformant of mouse myeloma cells J558L or NS-1 transformed with the plasmid pSV2-H1G1 are also provided.

    摘要翻译: 本发明提供增强子DNA片段,具有(a)增强子DNA片段和(b)结构基因如人D,V和J基因的基因片段和启动子。 具有来自Charon 4A噬菌体载体的噬菌体DNA片段和人DNA片段的杂交DNA(1),含有杂合DNA(1)的Charon 4A噬菌体,具有PBR322片段和人DNA片段的杂交DNA(2),转化体 通过将人DNA片段插入载体pSV-2gpt得到的质粒pSV2-H1G1,用质粒pSV2-H1G1转化的大肠杆菌MC1000菌株的转化体,和 还提供了用质粒pSV2-H1G1转化的小鼠骨髓瘤细胞J558L或NS-1的转化体。

    cDNA and genomic DNA encoding the amino acid sequence of human
.alpha..sub.2 -plasmin inhibition
    5.
    发明授权
    cDNA and genomic DNA encoding the amino acid sequence of human .alpha..sub.2 -plasmin inhibition 失效
    编码人α2-纤溶酶抑制的氨基酸序列的cDNA和基因组DNA

    公开(公告)号:US5221738A

    公开(公告)日:1993-06-22

    申请号:US803896

    申请日:1991-12-09

    IPC分类号: C07K14/81 C12N15/55

    CPC分类号: C07K14/8121

    摘要: cDNA encoding a human .alpha..sub.2 -plasmin inhibitor precursor protein represented by an amino acid sequence from the -39th Met to the 452nd Lys in FIG. 1 of the accompanying drawings; an amino acid sequence of a human .alpha..sub.2 -plasmin inhibitor precursor represented by an amino acid sequence from the -39th Met to the 452nd Lys in FIG. 1 of the accompanying drawings; and genomic DNA encoding a human .alpha..sub.2 -plasmin inhibitor protein which is composed of exons II, III, IV, V, VI, VII, VIII, IX and X in FIG. 4 of the accompanying drawings, said exons being bonded to one another via introns.

    摘要翻译: 编码人α2-纤溶酶原抑制物前体蛋白的cDNA,由图3中的第39位Met至第452位Lys的氨基酸序列表示。 附图1; 由图3中的第39位Met至第452位Lys的氨基酸序列表示的人α2-纤溶酶抑制剂前体的氨基酸序列。 附图1; 以及编码图2中由外显子II,III,IV,V,VI,VII,VIII,IX和X组成的人α2-纤溶酶抑制蛋白的基因组DNA。 附图4中,所述外显子通过内含子彼此结合。

    Process for producing diphenyls
    9.
    发明授权
    Process for producing diphenyls 失效
    生产二苯基的方法

    公开(公告)号:US4164518A

    公开(公告)日:1979-08-14

    申请号:US842312

    申请日:1977-10-14

    摘要: The oxidative coupling of benzene or benzene derivatives to form the corresponding diphenyls, comprising contacting benzene or a benzene derivative, such as toluene, with molecular oxygen using as a catalyst .beta.-diketo complexes of palladium such as acetylacetone-palladium complex. Use of at least one zirconium compound such as zirconium oxystearate in conjunction with the catalyst gives an increased catalytic activity. The diphenyls are intermediates for production of dyestuffs, pharmaceuticals and other chemicals, and also find application in the preparation of high-molecular-weight polyesters and polyamides.

    摘要翻译: 苯或苯衍生物的氧化偶联形成相应的二苯基,包括使用苯或苯衍生物如甲苯与分子氧接触,使用钯如乙酰丙酮 - 钯络合物的β-二酮络合物。 使用至少一种锆化合物如氧化硬脂酸锆与催化剂结合使用提高了催化活性。 二苯基是生产染料,药物和其他化学品的中间体,也可用于制备高分子量聚酯和聚酰胺。

    Process for preparing amino alcohols
    10.
    发明授权
    Process for preparing amino alcohols 失效
    制备氨基醇的方法

    公开(公告)号:US4151204A

    公开(公告)日:1979-04-24

    申请号:US771674

    申请日:1977-02-24

    CPC分类号: C07C215/08

    摘要: A process for preparing amino alcohols, which comprises reacting a polyhydric alcohol containing at least one primary alcoholic hydroxyl group and at least one secondary alcoholic hydroxyl group and expressed by the following general formula ##STR1## wherein R.sup.1 is an alkyl group, R.sup.2 and R.sup.3 are identical or different and represent a hydrogen atom or a lower alkyl group an n is an integer of 0 to 3,With ammonia in the presence of specified hydrogenation catalyst thereby to aminate the secondary alcoholic hydroxyl group of the polyhydric alcohol selectively.

    摘要翻译: 一种制备氨基醇的方法,其包括使含有至少一个伯醇羟基的多元醇与至少一种仲醇羟基反应,并由以下通式表示:其中R 1为烷基,R 2和R 3为 相同或不同,代表氢原子或低级烷基,n为0至3的整数,在规定的氢化催化剂存在下氨基酸可选择性地选择多官能醇的二级醇基羟基。